Facebook
Twitter
LinkedIn
Forward17th Annual Highlights of ASCO
This conference will introduce new therapies and information presented at the American Society of Clinical Oncology (ASCO®) Annual Meeting and will highlight the latest approaches to treating patients with cancer. Our faculty will share novel treatments and drug indications along with strategies to apply new treatments in daily practice. The ASCO® Annual Meeting is the world’s largest oncology conference and features practice-changing abstracts, studies, and review lectures.
This conference is being held in person and virtually.
Target Audience
This course is intended for physicians, nurses, pharmacists, and other interested health professionals.
Learning Objectives
At the end of this session, learners should be able to:
- Explain the advances in clinical and translational research presented at the 2024 ASCO® Annual Meeting
- Identify emerging trends and strategies designed to improve the quality of symptom management and survivorship care
- Evaluate tools and resources in specific areas of cancer management that can be used to achieve effective cancer care delivery and improve the patient experience
Faculty
Speakers
Earle Burgess, MD; Oncologist, Atrium Health Levine Cancer Institute
Lawrence Einhorn, MD; Livestrong Foundation Professor of Oncology; Distinguished Professor of Medicine, Department of Medicine, Indiana University
Brad Kahl, MD; Professor, Department of Medicine, Oncology Division; Director, Lymphoma Program, Washington University, St. Louis, MO
Rubina Qamar, MD; Clinical Adjunct Professor, Department of Medicine, UW School of Medicine and Public Health
Jon Richards, MD; Oncologist, Advocate Medical Group - Park Ridge
Nataliya Uboha, MD, PhD; Faculty Leader for Cancer Therapy Discovery & Development/Phase I Program; Associate Professor, Department of Medicine, Section of Hematology & Oncology University of Wisconsin
Planning Committee
Michael Mullane, MD; Medical Oncologist, Aurora Cancer Care; Medical Director, Hereditary Cancer Prevention and Management Center, Advocate Health – Midwest
James Weese, MD, FACS; Vice President, Cancer Service Line and Clinical Adjunct Professor of Surgery UW School of Medicine & Public Health, Advocate Health – Midwest
Corey Shamah, MD; Medical Director, Hematology / Oncology, Advocate Health – Midwest
Antony Ruggeri, MD; Co-Director Oncology Precision Medicine Program; Advocate Health – Midwest
Ellen Feinstein, RD, MHA, LFACHE; Vice President, Cancer Service Line Administration, Advocate Health- Midwest
Meghan McHugh, RN, BSN, OCN; Manager Clinical Cancer Service Line, Aurora Baycare Medical Center
Mark Hamm, PharmD, MBA, BCSCP; Pharmacy Director, Aurora St. Luke's Medical Center
Connie Kocourek, RN; Quality Improvement Coordinator, Aurora Cancer Care
Susan Phelan, MM, BSN, RN; Quality Improvement Coordinator, Grafton Cancer Care Clinic
Disclosure
Faculty disclosures are being reviewed and will be presented to the audience in advance of the program.
Accreditation Statement
In support of improving patient care, Advocate Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Statement(s)
American Medical Association (AMA)
Advocate Health designates this live activity for a maximum of 3.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC)
Advocate Health designates this live activity for a maximum of 3.25 ANCC contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
Accreditation Council for Pharmacy Education (ACPE)
Advocate Health designates this live activity for a maximum 3.25 hours of CPE credit for (pharmacists and pharmacy technicians). CPE credit can be claimed on the AAH CE platform within 60 days of activity completion and information will be provided to CPE Monitor. Participants should only claim credit commensurate with the extent of their participation in the activity.
Available Credit
- 3.25 AMA PRA Category 1 Credit™Aurora Health Care is accredited by the Wisconsin Medical Society to provide continuing medical education for physicians. Aurora Health Care designates this activity for a maximum of 3.25 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
- 3.25 AttendanceAttendance Credit
- 3.25 Approved AMA PRA Category 1 Credit™
- 3.25 Continuing Nursing Education (CE)Aurora Health Care is an approved provider of continuing nursing education by the Wisconsin Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. 3.25 contact hours have been awarded to this activity by the Wisconsin Nursing Association. To receive contact hours, participants must attend the entire activity.
- 3.25 Continuing Pharmacy Education (CPE)Aurora Health Care Department of Pharmacy Services is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Price
Click “Take Course” to register for this program.
This conference is being held in person and virtually. For those attending virtually, a link to the meeting will be provided prior to the event.
If you have any questions, please contact the IPCE Office at cme@aah.org